Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
CANCER
Log In
NICE Nixes Lapatinib, Trastuzumab With Aromatase Inhibitors for Some Breast Cancer
Have an interest in this Story?
Sign Up for Real-Time email updates
Oncology Report
|
February 14, 2012
Englandâ??s clinical and cost-effectiveness agency has said that it would not recommend lapatinib or trastuzumab with aromatase inhibitors as first-line treatments for postmenopausal women with HER2 positive metastatic breast cancer. The new negative draft guidance follows previous negative guidance...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read Cancer Articles
A balanced diet is key to childhood nutrition
- CHINAdaily
New approach tested for hard-to-treat hypertension
- Philadelphia Inquirer
Nickel allergy in relation to piercing and orthodontic appliances—a population study
- Journal of Contact Dermatitis
Vitamin D might be beneficial for...
- Today Online
Reimagining Personal Health Devices
- Physicians Practice
Featured Members
Robert Miller
Member/Manager
Healthcare Industry
Dr. Monte Hessler
Chiropractic care for Phoenix, Arizona
Healthcare General
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2012 Congoo.com. All Rights Reserved.